WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$101.10
−3.67%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- $0.07
- Revenue estimate
- $123.0M
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- $0.01
- EPS estimate
- -$0.19
- Revenue actual
- $114.4M
- Revenue estimate
- $111.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +41.5%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $79
- PT range
- $63 – $90
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.19 | $0.01 | Beat 105.32% | $114.4M |
| May 4, 2026 | -$0.06 | -$0.28 | Miss -366.67% | $102.3M |
| Feb 23, 2026 | $0.11 | $0.14 | Beat 27.27% | $121.0M |
| Jul 29, 2025 | $0.10 | $0.50 | Beat 400.00% | $102.7M |
| Apr 30, 2025 | $0.11 | $0.28 | Beat 154.55% | $87.1M |
| Feb 18, 2025 | $0.04 | $0.70 | Beat 1650.00% | $95.6M |
| Feb 20, 2024 | -$0.60 | -$0.59 | Beat 1.67% | $57.4M |
| Mar 14, 2023 | -$0.16 | -$0.25 | Miss -56.25% | $61.4M |
| Nov 14, 2022 | -$0.21 | -$0.20 | Beat 4.76% | $83.2M |
| Aug 15, 2022 | -$0.21 | -$0.25 | Miss -19.05% | $36.2M |
| May 12, 2022 | -$0.31 | -$0.31 | In line | $53.9M |
| Mar 14, 2022 | -$0.26 | -$0.17 | Beat 34.62% | $57.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026